Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. 1988

G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
Institute of Comparative and Experimental Pathology, University of Heidelberg, FRG.

The percentage of cells in S-phase and DNA-ploidy have been measured in 300 primary mammary carcinomas by means of DNA-flow cytometry (FCM). The data were compared with the age and menopausal status of the patients as well as with the size, regional lymph-node involvement, histologic type, grade and concentration of estrogen (ER) and progesterone (PR) receptors of the tumors. A DNA-diploid distribution of the G0/1-peak was found in 37.6% of the cases. The mean percentage of S-phase fractions was 4.83. DNA-aneuploid tumors had significantly higher amounts of S-phase fractions (6.12%) than DNA-diploid tumors (2.66%). There was also a significant correlation between the DNA measurement data (DNA-ploidy and S-phase fractions) and histologic grade, as well as the content of ER and PR, but not between DNA-ploidy, S-phase fractions, tumor size (T) and evidence of axillary lymph-node metastases. DNA-FCM gives a biological characterization of the tumor in addition to the histopathologic examination. The method can be used as a routine procedure because of the reliability and reproducibility of the results as well as the short time needed for the measurements.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004171 Diploidy The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X. Diploid,Diploid Cell,Cell, Diploid,Cells, Diploid,Diploid Cells,Diploidies,Diploids
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females

Related Publications

G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 1990, Cancer investigation,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 1993, Gynakologisch-geburtshilfliche Rundschau,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
August 1992, The Indian journal of medical research,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 1991, Gynakologische Rundschau,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 2002, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 1992, European journal of cancer (Oxford, England : 1990),
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
December 1987, Journal of clinical pathology,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
March 1993, Cancer,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
January 1988, European journal of gynaecological oncology,
G E Feichter, and A Mueller, and M Kaufmann, and D Haag, and I A Born, and U Abel, and K Klinga, and F Kubli, and K Goerttler
July 1994, American journal of clinical pathology,
Copied contents to your clipboard!